Gattex approved for short bowel syndrome
(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.
Medications
Dec 22, 2012 |
1 / 5 (1) |
1
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
Iclusig approved for rare leukemias
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Cancer
Dec 16, 2012 |
not rated yet |
0
Severe morning sickness patients get relief from anti-seizure drug, professor has found
(Medical Xpress)—Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a University at Buffalo professor ...
Obstetrics & gynaecology
Dec 10, 2012 |
5 / 5 (1) |
0
|
15 in hospital after Rhine river cruise infection
Fifteen people on a Rhine river cruise were rushed to hospitals in France and Germany after suffering nausea and vomiting, French and German rescue services said Sunday.
Diseases, Conditions, Syndromes
Dec 10, 2012 |
not rated yet |
0
FDA: Zofran 32-mg dose pulled from market
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according ...
Medications
Dec 06, 2012 |
not rated yet |
0
Predictors of postpartum pelvic joint pain identified among working women
A new study of working women has identified factors during pregnancy and postpartum that can predict pain in the joints that comprise the pelvic girdle. While 90 percent of working women in the Netherlands return to work ...
Health
Dec 04, 2012 |
not rated yet |
0
Hyperemesis gravidarum: no ordinary morning sickness
For anyone who has had hyperemesis gravidarum, the pregnancy-induced vomiting that has caused Prince William's wife Kate to be hospitalised, the term "morning sickness" is way off the mark.
Diseases, Conditions, Syndromes
Dec 04, 2012 |
not rated yet |
0
Cometriq approved for rare thyroid cancer
(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.
Medications
Nov 29, 2012 |
not rated yet |
0
Superbugs blasted by aerosols
(Medical Xpress)—Blasting superbugs with tiny nano-sized antibiotics delivered via powder aerosol may be a faster, safer and cheaper way of treating respiratory infectious diseases such as pneumonia or ...
Diseases, Conditions, Syndromes
Nov 29, 2012 |
4 / 5 (1) |
0
New study finds majority of pregnant women require an average of two months sick leave from work
Three quarters of pregnant women take sick leave from work but employers can help reduce this through flexible work adjustments, suggests a new study published today (7 November) in BJOG: An International Journal of Obstetrics an ...
Health
Nov 07, 2012 |
not rated yet |
0
Synribo approved to treat rare leukemia
(HealthDay)—Synribo (omacetaxine mepesuccinate) has been approved by the U.S. Food and Drug Administration to treat a rare blood and bone marrow disease called chronic myelogenous leukemia (CML).
Cancer
Oct 26, 2012 |
not rated yet |
0
Marijuana use may cause severe cyclic nausea, vomiting, a little-known, but costly effect
Marijuana use—both natural and synthetic—may cause cannabinoid hyperemesis (CH) a little-known but costly effect that researchers suggest is a serious burden to the health care system as it often leads to expensive diagnostic ...
Health
Oct 22, 2012 |
1 / 5 (2) |
0
Abraxane approved to treat advanced lung cancer
(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung ...
Cancer
Oct 14, 2012 |
not rated yet |
0
New research looks to reduce animal testing for drug development
Researchers from Royal Holloway, University of London are looking at ways of testing the side effects of new drugs without using animals.
Medical research
Oct 10, 2012 |
5 / 5 (1) |
0
